Innovation Bridge: Linking Biotech Breakthroughs to Emerging Vaccine Manufacturers

With a team of researchers, economists and physician-scientists, Matthew Davis of the University of Michigan will establish a program to link new vaccine discoveries with vaccine manufacturers in developing countries while simultaneously evaluating ways to help these manufacturers purchase rights to these innovative candidates.